<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Drug safety / Clinical pharmacology / Clinical research / Clinical trials / Pharmacovigilance / Adverse effect / Adverse drug reaction / Suspected Adverse Reaction Surveillance Scheme / VigiBase
Date: 2016-07-27 06:22:22
Pharmaceuticals policy
Drug safety
Clinical pharmacology
Clinical research
Clinical trials
Pharmacovigilance
Adverse effect
Adverse drug reaction
Suspected Adverse Reaction Surveillance Scheme
VigiBase

SUSPECTED ADVERSE DRUG REACTION (ADR) REPORTING FORM CONFIDENTIAL If you are suspicious that an adverse reaction may be related to a drug or a combination of drugs, PLEASE COMPLETE THIS FORM and send it to the nearest Ph

Add to Reading List

Source URL: dra.gov.bt

Download Document from Source Website

File Size: 375,03 KB

Share Document on Facebook

Similar Documents

Findings that shed new light on the possible pathogenesis of a disease or an adverse effect Chronic carbon monoxide poisoning resulting in bilateral cataracts and a cystic globus pallidus lesion Shivani Kasbekar,1 Jose A

DocID: 1uw60 - View Document

Press contact: Eric Young, , (orcell) Experiment suggests that pop-up ads can have an adverse effect on consumers’ perceptions of the content. CHICAGO, April 18, 2017

DocID: 1tKSS - View Document

Medicine / Clinical medicine / Chemistry / Lactones / Enzyme inhibitors / Formamides / Aldehydes / Hoffmann-La Roche / Orlistat / Anti-obesity medication / Adverse effect / Sibutramine

orlistat and pcoc orlistat 60 mg studies persistence analysis sibutramine orlistat, clinical studies orlistat, orlistat and gall stones does orlistat work, health problems and orlistat orlistat and appetite. orlistat pre

DocID: 1rrCO - View Document

Pharmaceutical sciences / Pharmacology / Pharmaceuticals policy / Health care / Pharmacy / Drugs / Clinical pharmacology / Pharmaceutical industry / Formulary / Prescription drug / Pharmaceutical drug / Adverse effect

NON-INSURED HEALTH BENEFITS First Nations and Inuit Health Branch DRUG BENEFIT LIST 2016

DocID: 1rp6w - View Document

Medicine / Neurochemistry / Clinical medicine / RTT / General anesthetics / Dosage forms / Calcium channel blockers / Sodium channel blockers / Ketamine / Adverse effect / Intravenous therapy / FOLFOX

Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform

DocID: 1reFq - View Document